- Home
- NVST vs PCVX Comparison
NVST vs PCVX Comparison
Compare NVST & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVST
- PCVX
- Stock Information
- Founded
- NVST 2018
- PCVX 2013
- Country
- NVST United States
- PCVX United States
- Employees
- NVST N/A
- PCVX N/A
- Industry
- NVST Medical/Dental Instruments
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- NVST Health Care
- PCVX Health Care
- Exchange
- NVST Nasdaq
- PCVX Nasdaq
- Market Cap
- NVST 3.4B
- PCVX 4.0B
- IPO Year
- NVST 2019
- PCVX 2020
- Fundamental
- Price
- NVST $20.42
- PCVX $41.62
- Analyst Decision
- NVST Buy
- PCVX Strong Buy
- Analyst Count
- NVST 12
- PCVX 8
- Target Price
- NVST $20.91
- PCVX $114.17
- AVG Volume (30 Days)
- NVST 2.0M
- PCVX 2.0M
- Earning Date
- NVST 10-30-2025
- PCVX 11-04-2025
- Dividend Yield
- NVST N/A
- PCVX N/A
- EPS Growth
- NVST N/A
- PCVX N/A
- EPS
- NVST 0.31
- PCVX N/A
- Revenue
- NVST $2,552,900,000.00
- PCVX N/A
- Revenue This Year
- NVST $6.55
- PCVX N/A
- Revenue Next Year
- NVST $3.33
- PCVX N/A
- P/E Ratio
- NVST $65.47
- PCVX N/A
- Revenue Growth
- NVST 0.76
- PCVX N/A
- 52 Week Low
- NVST $14.22
- PCVX $27.66
- 52 Week High
- NVST $23.00
- PCVX $118.62
- Technical
- Relative Strength Index (RSI)
- NVST 46.50
- PCVX 72.10
- Support Level
- NVST $20.28
- PCVX $31.89
- Resistance Level
- NVST $21.24
- PCVX $43.76
- Average True Range (ATR)
- NVST 0.52
- PCVX 1.88
- MACD
- NVST -0.03
- PCVX 1.04
- Stochastic Oscillator
- NVST 39.40
- PCVX 82.12
About NVST Envista Holdings Corporation
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.